Answers are grounded in this paper and cite their sources.
Graphical abstract ABSTRACT This study aimed to isolate a novel antimony-mineralizing bacterium and elucidate its molecular response mechanisms during Sb(III) biomineralization via integrated multi-omics. The isolate Serratia marcescens (MIC > 250 mM) achieved 96.18% Sb(III) removal under Box-Behnken-optimized conditions (27.7 ℃, pH 4.67, 205.6 rpm). Timeseries Raman and SEM-EDS revealed a nonclassical crystallization pathway proceeding through an amorphous precursor to crystalline Sb2O3 (confirmed by XRD/XPS) within 36 h. Integrated transcriptomic and proteomic profiling showed that Sb(III) stress significantly upregulated TCA cycle enzymes (mqo, mdh, fumC), fatty acid βoxidation (FadL/D/E/A), siderophore/iron uptake (entB/C/E, fepB/A), Fe-S cluster assembly (sufABCS), molybdenum cofactor biosynthesis (moaABCDE), and glutathionemediated antioxidant systems (katCEG, gshAB), while concurrently downregulating flagellar assembly (flgBCDEFGKL) and chemotaxis (cheR) to conserve proton motive force for ArsB-driven Sb(III) efflux. S. marcescens orchestrates a coordinated metabolic reprogramming that enhances energy generation, metal sequestration, and oxidative defence while suppressing motility, effectively transforming toxic aqueous Sb(III) into valuable crystalline Sb2O3. These findings provide a mechanistic blueprint for engineering microbialbased bioremediation and resource recovery from antimonypolluted environments.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: